Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

InterCure Ltd. (INCR)

6.07   -0.2 (-3.19%) 08-08 01:13
Open: 6.15 Pre. Close: 6.27
High: 6.275 Low: 6.07
Volume: 18,224 Market Cap: 280(M)
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.28 - 6.31 6.31 - 6.33
Low: 5.99 - 6.04 6.04 - 6.06
Close: 6.01 - 6.07 6.07 - 6.11

Technical analysis

as of: 2022-08-05 4:23:00 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 7.58     One year: 8.85
Support: Support1: 5.96    Support2: 5.63
Resistance: Resistance1: 6.48    Resistance2: 7.58
Pivot: 6.09
Moving Average: MA(5): 6.13     MA(20): 6.02
MA(100): 6.3     MA(250): 6.63
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 55.6     %D(3): 57.5
RSI: RSI(14): 50.6
52-week: High: 8.77  Low: 5.42
Average Vol(K): 3-Month: 42 (K)  10-Days: 17 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ INCR ] has closed above bottom band by 46.1%. Bollinger Bands are 51.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Sat, 06 Aug 2022
Patient perception -switching to generic dry powder inhaler | COPD - Dove Medical Press

Fri, 05 Aug 2022
No evidence Michels personally pushed for gas tax increase, despite ties to groups that did - PolitiFact

Thu, 04 Aug 2022
Premier, Inc. Declares an Incr -

Mon, 01 Aug 2022
Treasury Department says borrowing needs have increased by $262 billion - Washington Times

Mon, 01 Aug 2022
Cannabis Stocks Earnings Season Starts This Week - New Cannabis Ventures

Wed, 27 Jul 2022
Energy Transfer Announces Incr -

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. 45 (M)
Shares Float 26 (M)
% Held by Insiders 38 (%)
% Held by Institutions 14.2 (%)
Shares Short 22 (K)
Shares Short P.Month 50 (K)

Stock Financials

EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 2.1
Operating Margin (%) 0
Return on Assets (ttm) 3.7
Return on Equity (ttm) 1.9
Qtrly Rev. Growth 194.1
Gross Profit (p.s.) 2.27
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.